NFKB1 and neoplasm: Growing evidences have demonstrated that aPKCι activates NF-κB signaling in multiple tumor types [20–22] and that NF-κB is a major transcription factor associated with the immune microenvironment [23, 24], chemoresistance [25] and EMT [26, 27].